These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 27272814)

  • 1. ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Chen YL; Chen PM; Lin PY; Hsiau YT; Chu PY
    Anticancer Res; 2016 Jun; 36(6):2983-8. PubMed ID: 27272814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.
    Zen Y; Fujii T; Yoshikawa S; Takamura H; Tani T; Ohta T; Nakanuma Y
    Am J Pathol; 2007 May; 170(5):1750-62. PubMed ID: 17456779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(4):367-76. PubMed ID: 23394449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.
    Jing YY; Liu WT; Guo SW; Ye F; Fan QM; Yu GF; Yu DD; Gao L; Sun K; Han ZP; Li R; Yang Y; Zhao QD; Wu MC; Wang HY; Wei LX
    Oncotarget; 2015 Dec; 6(40):42952-62. PubMed ID: 26515593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
    Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
    Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
    Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
    BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of transporter associated with antigen processing 1 and tumor necrosis factor alpha expression in hepatitis B virus-related hepatocellular carcinoma and peritumor cirrhosis tissues using tissue chip technology.
    Qiu B; Jiang W; Zhang J; Wang Y; Wei F; Hu H; Zhang P; Shi C; Zhang J
    Hepatogastroenterology; 2013; 60(121):14-8. PubMed ID: 23682387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of relaxin-2 expression in hepatocellular carcinoma: relation with clinicopathological parameters.
    Pan HZ; Dong AB; Wang L; Tan SS; Yang Q; Tong XY; Liang J; Wang JR
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1095-101. PubMed ID: 23661524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
    Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
    Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.